417 related articles for article (PubMed ID: 27161218)
1. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Ghallab NA; Shaker OG
Clin Oral Investig; 2017 Apr; 21(3):937-947. PubMed ID: 27161218
[TBL] [Abstract][Full Text] [Related]
2. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
4. Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta Analysis.
Hema Shree K; Ramani P; Sherlin H; Sukumaran G; Jeyaraj G; Don KR; Santhanam A; Ramasubramanian A; Sundar R
Pathol Oncol Res; 2019 Apr; 25(2):447-453. PubMed ID: 30712193
[TBL] [Abstract][Full Text] [Related]
5. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
[TBL] [Abstract][Full Text] [Related]
6. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
7. Salivary MMP-9 in the detection of oral squamous cell carcinoma.
Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; Hennings J; Schultze-Mosgau S
Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e270-275. PubMed ID: 28160595
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of salivary sialic acid as a tumor marker in tobacco chewers with oral cancer.
Azeem MS; Yesupatham ST; Mohiyuddin SMA; Sumanth V; Ravishankar S
J Cancer Res Ther; 2020; 16(3):605-611. PubMed ID: 32719275
[TBL] [Abstract][Full Text] [Related]
9. Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.
Chu HW; Chang KP; Hsu CW; Chang IY; Liu HP; Chen YT; Wu CC
Mol Cell Proteomics; 2019 Sep; 18(9):1796-1806. PubMed ID: 31253657
[TBL] [Abstract][Full Text] [Related]
10. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
[TBL] [Abstract][Full Text] [Related]
11. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma.
Metgud R; Bajaj S
Biotech Histochem; 2016; 91(2):96-101. PubMed ID: 26529498
[TBL] [Abstract][Full Text] [Related]
12. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
Shin YJ; Vu H; Lee JH; Kim HD
PLoS One; 2021; 16(3):e0248167. PubMed ID: 33735248
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of synuclein-γ levels by novel monoclonal antibody in saliva and cancer tissues from oral squamous cell carcinoma patients.
Wang K; Shen Y; Xu J; Li Z; Liu Y; Yu C; Peng L; Zheng J; Zeng Y
Neoplasma; 2020 May; 67(3):707-713. PubMed ID: 32202903
[TBL] [Abstract][Full Text] [Related]
16. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity.
Rajkumar K; Nandhini G; Ramya R; Rajashree P; Kumar AR; Anandan SN
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Sep; 118(3):309-19. PubMed ID: 24950604
[TBL] [Abstract][Full Text] [Related]
17. Investigating the level of salivary endothelin-1 in premalignant and malignant lesions.
Nosratzehi T; Risbaf Fakour S; Alijani E; Salehi M
Spec Care Dentist; 2017 May; 37(3):134-139. PubMed ID: 28199027
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
Cai M; Zheng Z; Bai Z; Ouyang K; Wu Q; Xu S; Huang L; Jiang Y; Wang L; Gao J; Pathak JL; Wu L
BMC Cancer; 2022 May; 22(1):530. PubMed ID: 35545767
[TBL] [Abstract][Full Text] [Related]
19. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
20. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
